The FDA has granted fast-track designation to nipocalimab for the treatment of Sjögren’s disease, according to a press ...

Otsuka’s Taiho Pharmaceutical is paying $400 million upfront to acquire Switzerland’s Araris Biotech and its antibody-drug ...

Complementing its antibody offerings, BosterBio provides a range of ELISA kits designed for quantitative detection of ...

Data highlights potential of CD388 as a potent, universal antiviral for influenza prevention regardless of immune statusSAN DIEGO, March 17, ...

Company expects to have sufficient cash to fund planned operations beyond the FDA PDUFA goal date and anticipated fourth ...

The Federal Circuit says that you must disclose and describe the prior art, or your Jepson claim is invalid. Obviously, this ...

After hours: March 17 at 4:05:11 PM EDT Loading Chart for FC ...

Taiho Pharmaceutical Co., Ltd.Araris Biotech AGTaiho Pharmaceutical to Acquire Next-Generation ADC Drug Discovery Company Araris ...

We expect these to return in EA FC 25 once again. The devs also like to throw new special card campaigns into the mix as well, but these won’t be announced until a day or two before they are due ...

Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based ...

FDA grants Fast Track designation to Johnson & Johnson’s investigational therapy nipocalimab for the treatment of moderate-to-severe Sjögren’s disease, which could be the first targeted therapy ever ...

In this free webinar, learn about advancements in cell line development and glycoengineering. Attendees will gain insights into how precise glycan modulation boosts antibody-dependent cell-mediated ...